Pulmonary Function and Neuromuscular Disease

Completed

• Conditions: Neuromuscular Diseases

• Registration Number: NCT03445832
• Lead Sponsor: Centre Hospitalier Universitaire de Besancon

Brief Summary

This study aims to describe the evolution of pulmonary function in 3 neuromuscular diseases : Duchenne muscular dystrophy, Werdnig-Hoffinann disease, congenital myopathy, monitored in Besançon university hospital.

Detailed Description

Not available

Study Timeline

• Study Start: 2018-01-08
• Primary Completion: 2018-02-10
• Study Completion: 2018-02-10
• Study First Submitted: 2018-02-20
• Study First Submitted QC: 2018-02-23
• Study First Posted: 2018-02-26
• Status Verified: 2018-08
• Last Update Submitted: 2018-08-16
• Last Update Posted: 2018-08-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 21

Inclusion Criteria

• Neuromuscular disease
• Followed-up in Besançon University Hospital
• With at least 2 Pulmonary Function Tests previously performed

Exclusion Criteria

• Mental deficiency
• Facial expressions disorders

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
FVC (Forced Vital Capacity)	Year 12	Percentage of decrease of FVC sitting or lying down

Trial Locations

Locations (1)

CHU de Besançon; 🇫🇷 Besançon, France